BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 30217385)

  • 1. Updates to the compensation plan for pharmacy services in Alberta, Canada.
    Breault RR; Schindel TJ; Whissell JG; Hughes CA
    J Am Pharm Assoc (2003); 2018; 58(6):597-598. PubMed ID: 30217385
    [No Abstract]   [Full Text] [Related]  

  • 2. Development and implementation of the compensation plan for pharmacy services in Alberta, Canada.
    Breault RR; Whissell JG; Hughes CA; Schindel TJ
    J Am Pharm Assoc (2003); 2017; 57(4):532-541. PubMed ID: 28623124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical pharmacist intervention in a primary care medical group reduces financial losses.
    Curtiss FR
    J Manag Care Pharm; 2004; 10(4):355. PubMed ID: 15298533
    [No Abstract]   [Full Text] [Related]  

  • 4. Spirometry: tool for pharmacy practitioners to expand direct patient care services.
    Cawley MJ; Moon J; Reinhold J; Willey VJ; Warning Ii WJ
    J Am Pharm Assoc (2003); 2013; 53(3):307-15. PubMed ID: 23699680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perceptions of pharmacists' roles in the era of expanding scopes of practice.
    Schindel TJ; Yuksel N; Breault R; Daniels J; Varnhagen S; Hughes CA
    Res Social Adm Pharm; 2017; 13(1):148-161. PubMed ID: 27061142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacist-provided immunization compensation and recognition: white paper summarizing APhA/AMCP stakeholder meeting.
    Skelton JB; ;
    J Am Pharm Assoc (2003); 2011; 51(6):704-12. PubMed ID: 22068191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Financial remuneration is positively correlated with the number of clinical activities: an example from diabetes management in Alberta community pharmacies.
    Bharadia R; Lorenz K; Cor K; Simpson SH
    Int J Pharm Pract; 2018 Feb; 26(1):77-80. PubMed ID: 28240395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compensation for cognitive services.
    Talley CR
    Am J Health Syst Pharm; 1995 Apr; 52(7):693. PubMed ID: 7627737
    [No Abstract]   [Full Text] [Related]  

  • 9. Better Care, Smarter Spending, Healthier Outcomes.
    McGann P
    Consult Pharm; 2016; 31(8):410-1. PubMed ID: 27535075
    [No Abstract]   [Full Text] [Related]  

  • 10. Costs of pharmaceutical care: can the profession do anything?
    Hopefl AW
    Ann Pharmacother; 1992 Dec; 26(12):1585-8. PubMed ID: 1482817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategies to improve compensation for pharmaceutical care services.
    Bennett MS; Blank D; Bopp J; James JA; Osterhaus MC
    J Am Pharm Assoc (Wash); 2000; 40(6):747-55. PubMed ID: 11111354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Managed care pharmacy sees potential of comparative effectiveness research to improve patient care and lower costs.
    Cahill J; Learner N
    Pharmacoeconomics; 2010; 28(10):931-4. PubMed ID: 20831301
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacists' acceptable levels of compensation for MTM services: a conjoint analysis.
    Wang J; Hong SH; Meng S; Brown LM
    Res Social Adm Pharm; 2011 Dec; 7(4):383-95. PubMed ID: 21272533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PharmacistCARE: description of a pharmacist care service and lessons learned along the way.
    Divine H; Nicholas A; Johnson CL; Perrier DG; Steinke DT; Blumenschein K
    J Am Pharm Assoc (2003); 2008; 48(6):793-802. PubMed ID: 19019810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Have consultant pharmacists provided value to long-term care payers?
    Vogenberg FR; Dhir S
    Consult Pharm; 2006 Jan; 21(1):72-5. PubMed ID: 16524354
    [No Abstract]   [Full Text] [Related]  

  • 16. Expanding professional pharmacy services in European community setting: Is it cost-effective? A systematic review for health policy considerations.
    Perraudin C; Bugnon O; Pelletier-Fleury N
    Health Policy; 2016 Dec; 120(12):1350-1362. PubMed ID: 28228230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacist provider status legislation: Projections and prospects.
    Harper PC
    J Am Pharm Assoc (2003); 2015; 55(2):203-7. PubMed ID: 25749265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-benefit and cost-savings analyses of antiarrhythmic medication monitoring.
    Snider M; Carnes C; Grover J; Davis R; Kalbfleisch S
    Am J Health Syst Pharm; 2012 Sep; 69(18):1569-73. PubMed ID: 22935939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transitional care CPT codes may include pharmacists' services.
    Traynor K
    Am J Health Syst Pharm; 2013 May; 70(9):748, 750. PubMed ID: 23592353
    [No Abstract]   [Full Text] [Related]  

  • 20. Current trends in outpatient pharmacy services and billing.
    Beatty SJ; McCormick KM; Beale DJ; Bruggeman AM; Rodis JL; Mehta BH; Bennett MS
    J Am Pharm Assoc (2003); 2012; 52(2):154-60. PubMed ID: 22370377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.